Mek1 alters epidermal growth and differentiation

Florence A Scholl1, Phillip A Dumesic, Paul A Khavari

  • 1VA Palo Alto Healthcare System, Palo Alto, California 94305, USA.

Cancer Research
|September 3, 2004
PubMed

Insights

Mek1 and Mek2 kinases activate ERK. Mek1, but not Mek2, drives epidermal hyperplasia and suppresses differentiation, mimicking neoplasia, even without kinase activity.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Dermatology

Background:

  • Mek1 and Mek2 are homologous kinases downstream of Ras/Raf, activating ERK.
  • Ras/Raf signaling in epidermis promotes hyperplasia via multiple effectors.
  • The specific roles of Mek1 and Mek2 in mediating Ras/Raf effects are not fully understood.

Purpose of the Study:

  • To investigate the distinct roles of Mek1 and Mek2 in epidermal signaling.
  • To determine the extent to which Mek kinases mediate Ras/Raf-driven epidermal hyperplasia.
  • To elucidate the mechanism by which Mek1 promotes epidermal proliferation.

Main Methods:

  • Expression of inducible Mek1 and Mek2 in transgenic murine and human epidermis.
  • Analysis of ERK phosphorylation levels.
  • Assessment of epidermal proliferation, differentiation, and integrin expression.
  • Utilizing a kinase-dead Mek1 mutant.

Main Results:

  • Both Mek1 and Mek2 induced ERK phosphorylation.
  • Mek1, but not Mek2, replicated Ras/Raf effects: increased proliferation, integrin expression, and suppressed differentiation.
  • A kinase-dead Mek1 mutant retained the ability to promote epidermal proliferation, independent of ERK phosphorylation.

Conclusions:

  • Mek1 is sufficient to induce the proliferative epithelial phenotype characteristic of neoplasia.
  • Mek1-driven epidermal proliferation can occur independently of its kinase activity.
  • Mek1 possesses functions beyond ERK activation that contribute to epidermal hyperplasia.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Cells of the Epidermis01:24

Cells of the Epidermis

The epidermis is made of four or five layers of epithelial cells, depending on its location in the body. From deep to superficial, these layers are the stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum.
The cells in all these layers except the stratum basale are called keratinocytes, a type of cell that manufactures and stores the protein keratin. The keratinocytes in the stratum corneum are dead and regularly slough away, being replaced by cells from...